The role of tissue factor and protease‐activated receptor 2 in endometriosis
article
OA: closed
CC0
⤵ 16 in-corpus citations
AI-generated summary
Tissue factor and protease-activated receptor 2 expression are upregulated in eutopic and ectopic endometrium of women with endometriosis, suggesting a role in lesion development.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PROBLEM: Little is known about the roles of TF and PAR-2 in endometriosis. This article investigated the expression of TF and PAR-2 in ectopic and eutopic endometrium with endometriosis and their relationship with the menstrual cycle. METHODS: Ectopic and eutopic endometrium tissues from 42 women with ovarian endometrioma and endometrium tissues from 20 women without endometriosis were obtained. All the samples were assessed for TF and PAR-2 protein location using immunohistochemistry and for relative TF and PAR-2 mRNA expression using real-time florescent quantitative polymerase chain reaction (FQ-PCR). RESULTS: Total TF and PAR-2 expression were significantly higher in ectopic and eutopic endometrium of women with endometriosis when compared with controls. Moreover, TF expression in ectopic and eutopic endometrium and PAR-2 expression in ectopic endometrium were significantly increased through the whole menstrual cycle. However, in eutopic endometrium with endometriosis, PAR-2 expression only in secretory phase was higher than its cycle-matched normal controls. There is no such difference in the proliferative phase. CONCLUSION: The abnormal co-upregulated expression of TF and PAR-2 in eutopic and ectopic endometrium may affect the development and growth of endometriotic lesions and highlighted the pathologic role of TF and PAR-2 in eutopic endometrium in endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (33)
- Activation of protease-activated receptor 2 stimulates proliferation and interleukin (IL)-6 and IL-8 secretion of endometriotic stromal cells via openalex
- Basic and Translational Research on Proteinase-Activated Receptors: Proteinase-Activated Receptors in Female Reproductive Tissues and Endometriosis via openalex
- Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis via openalex
- Endometrial expression of estrogen receptor β and its splice variants in patients with and without endometriosis via openalex
- Endometriosis Gene Expression Heterogeneity and Biosignature: A Phylogenetic Analysis via openalex
- <i>Endometriosis and Tissue Factor</i> via openalex
- Medical treatments for endometriosis. via openalex
- Mysteries of endometriosis pain: Chien‐Tien Hsu Memorial Lecture 2009 via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Role of Endometriosis in Cancer and Tumor Development via openalex
- Role of Eutopic Endometrium in Pelvic Endometriosis via openalex
- W2098811053 via openalex
- W2103156802 via openalex
- W2114960395 via openalex
- W2123134517 via openalex
- W2128662183 via openalex
- W2132687591 via openalex
- W2140246703 via openalex
- W2204640292 via openalex
- W4211081176 via openalex
- W4214726381 via openalex
- W6603618881 via openalex
- W6809607798 via openalex
- W1966574709 via openalex
- W1978546515 via openalex
- W2000311445 via openalex
- W2023917273 via openalex
- W2024905084 via openalex
- W2029246353 via openalex
- W2047187862 via openalex
- W2067201007 via openalex
- W2068655393 via openalex
- W2079190330 via openalex
Cited by (17)
- L-ICON3 Suppresses Endometriosis in a Murine Model 2026
- The characteristics of the hemostatic system in patients with external genital endometriosis 2023
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Impact of Continuous Estroprogestin Treatment on Circulating Microparticle Levels in Deep Endometriosis Patients 2023
- The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions 2021
- Assessment of Coagulation Parameters in Women Affected by Endometriosis: Validation Study and Systematic Review of the Literature 2020
- Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis? 2019
- A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 2019
- Investigational drugs for the treatment of endometriosis, an update on recent developments 2018
- Coagulation Status in Women With Endometriosis 2017
- Endometriosis-Derived Stromal Cells Secrete Thrombin and Thromboxane A2, Inducing Platelet Activation 2016
- Endometrial biomarkers for the non-invasive diagnosis of endometriosis 2016
- Total circulating microparticle levels are increased in patients with deep infiltrating endometriosis 2016
- Different Expression of Hypoxic and Angiogenic Factors in Human Endometriotic Lesions 2015
- Recent Advances in Gene Therapy of Endometriosis 2014
- ENMD-1068, a protease-activated receptor 2 antagonist, inhibits the development of endometriosis in a mouse model 2014
- The Endometriotic Tissue Lining the Internal Surface of Endometrioma: Hormonal, Genetic, Epigenetic Status, and Gene Expression Profile 2014
Source provenance
- europepmc
- last seen: 2026-09-19T06:15:14.566301+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:16:11.197438+00:00
License: CC0
· commercial use OK